JIN MEDICAL INTERNATIONAL LTD. - Class A Ordinary Shares (ZJYL)
Healthcare › Orthopedic, Prosthetic & Surgical Appliances & Supplies
Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 34% below Graham Number ($0.18) — significant margin of safety
- Piotroski F-Score 4/9 — moderate financial health
- ROE of 4.0% — below-average profitability
- Revenue declining 12% annually
JIN MEDICAL INTERNATIONAL LTD. - Class A Ordinary Shares (ZJYL) is a Healthcare company operating in Orthopedic, Prosthetic & Surgical Appliances & Supplies, listed on the NASDAQ , with a market capitalisation of $18 million . Key value metrics: P/E ratio 15.5, P/B ratio 0.62, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
JIN MEDICAL INTERNATIONAL LTD. - Class A Ordinary Shares — Fundamental Analysis Summary
JIN MEDICAL INTERNATIONAL LTD. - Class A Ordinary Shares (ZJYL) is trading 34% below its Graham Number of $0.18 — a significant margin of safety by Benjamin Graham's standard. The stock carries a reasonable trailing P/E ratio of 15.5x.
On financial health, ZJYL shows a moderate Piotroski F-Score of 4/9, and modest return on equity of 4.0% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.64.
StockPik's composite Value Score for ZJYL is 78/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ZJYL reports a moderate gross margin of 29.2% (sector average: 33.5%) and a modest operating margin of 2.9%.
ZJYL shows revenue declining at 12% year-over-year, with earnings declining at 68%.